{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05683184",
            "orgStudyIdInfo": {
                "id": "2000033525"
            },
            "secondaryIdInfos": [
                {
                    "id": "1R21DA052864-01A1",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/1R21DA052864-01A1"
                },
                {
                    "id": "2K12DA000167-31",
                    "type": "NIH",
                    "link": "https://reporter.nih.gov/quickSearch/2K12DA000167-31"
                }
            ],
            "organization": {
                "fullName": "Yale University",
                "class": "OTHER"
            },
            "briefTitle": "OMAR Opioid Use Disorder",
            "officialTitle": "Characterization of CB1 Receptors Using [11-C]OMAR in Opioid Use Disorder",
            "therapeuticArea": [
                "Other"
            ],
            "study": "omar-opioid-use-disorder"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-10",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-12-15",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-15",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-12-20",
            "studyFirstSubmitQcDate": "2023-01-03",
            "studyFirstPostDateStruct": {
                "date": "2023-01-13",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-05",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-09",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Anahita Bassir Nia",
                "investigatorTitle": "Assistant Professor of Psychiatry",
                "investigatorAffiliation": "Yale University"
            },
            "leadSponsor": {
                "name": "Yale University",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Institute on Drug Abuse (NIDA)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The goal of this research study is to examine the endocannabinoid (eCB) function in vivo in individuals with opioid use disorder (OUD) by measuring cannabinoid receptor 1 (CB1R) availability.",
            "detailedDescription": "The investigators will image brain cannabinoid receptors using Positron Emission Tomography (PET) imaging and the radioligand \\[11C\\] OMAR, in healthy individuals and individuals diagnosed with opioid use disorder. Research participants may complete screening, MRI, PET scan and follow up visits."
        },
        "conditionsModule": {
            "conditions": [
                "Healthy Control",
                "Opioid Use Disorder"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "DIAGNOSTIC",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Healthy Volunteers",
                    "type": "OTHER",
                    "description": "Healthy volunteers with no current or past major medical or psychiatric history",
                    "interventionNames": [
                        "Drug: [11C]OMAR"
                    ]
                },
                {
                    "label": "Opioid Use Disorder",
                    "type": "OTHER",
                    "description": "Patients diagnosed with opioid use disorder",
                    "interventionNames": [
                        "Drug: [11C]OMAR"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "[11C]OMAR",
                    "description": "For each \\[11C\\]OMAR PET scan, up to 20 mCi of \\[11C\\]OMAR will be administered.",
                    "armGroupLabels": [
                        "Healthy Volunteers",
                        "Opioid Use Disorder"
                    ],
                    "otherNames": [
                        "[11C] JHU75528"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "CB1R Availability",
                    "description": "To compare cortical CB1R availability in individuals diagnosed with opioid use disorder on chronic methadone maintenance vs. matched healthy controls.",
                    "timeFrame": "One time within 4 weeks of screening"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Serum Endocannabinoid Levels",
                    "description": "To explore group differences in serum endocannabinoid levels in individuals diagnosed with opioid use disorder on chronic methadone maintenance vs. matched healthy controls.",
                    "timeFrame": "One time within 4 weeks of screening"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Able to provide informed consent\n* Male and female 18 years and older\n* DSM-5 diagnosis of opioid use disorder (for OUD group)\n* Physically healthy i.e., no clinically unstable medical conditions\n* Written informed consent and have capacity to consent and comply with study procedures\n\nExclusion Criteria:\n\n* Current neuro-psychiatric illness or severe systemic disease (opioid use disorder is permitted in the OUD group).\n* Presence of ferromagnetic metal in the body or heart pacemaker\n* Have had exposure to ionizing radiation that in combination with the study tracer would result in a cumulative exposure that exceeds recommended exposure limits\n* Are claustrophobic",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Anahita Bassir Nia, MD",
                    "role": "CONTACT",
                    "phone": "203-974-7540",
                    "email": "anahita.bassirnia@yale.edu"
                },
                {
                    "name": "Angelina Contreras",
                    "role": "CONTACT",
                    "phone": "203-626-1105",
                    "email": "angelina.contreras@yale.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Anahita Bassir Nia, MD",
                    "affiliation": "Yale University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Connecticut Mental Health Center, Clinical Neuroscience Research Unit",
                    "status": "RECRUITING",
                    "city": "New Haven",
                    "state": "Connecticut",
                    "zip": "06519",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Angelina Contreras, BS",
                            "role": "CONTACT",
                            "phone": "203-626-1105",
                            "email": "angelina.contreras@yale.edu"
                        },
                        {
                            "name": "Anahita Bassir Nia, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.30815,
                        "lon": -72.92816
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009293",
                    "term": "Opioid-Related Disorders"
                },
                {
                    "id": "D000019966",
                    "term": "Substance-Related Disorders"
                }
            ],
            "ancestors": [
                {
                    "id": "D000079524",
                    "term": "Narcotic-Related Disorders"
                },
                {
                    "id": "D000064419",
                    "term": "Chemically-Induced Disorders"
                },
                {
                    "id": "D000001523",
                    "term": "Mental Disorders"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12244",
                    "name": "Opioid-Related Disorders",
                    "asFound": "Opioid Use Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21837",
                    "name": "Substance-Related Disorders",
                    "asFound": "Opioid Use Disorder",
                    "relevance": "HIGH"
                },
                {
                    "id": "M2057",
                    "name": "Narcotic-Related Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M30302",
                    "name": "Chemically-Induced Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M4815",
                    "name": "Mental Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M14473",
                    "name": "Psychotic Disorders",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC25",
                    "name": "Substance Related Disorders"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "M4033",
                    "name": "Analgesics, Opioid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Analg",
                    "name": "Analgesics"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}